Sio Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Sio Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-41,714	Closed	-$142K	–	75
2017 Q1	$142K	Buy	+41,714	New	+$197K	0.08%	46
2016 Q4	–	Sell	-112,639	Closed	-$2.84M	–	54
2016 Q3	$2.84M	Sell	112,639 -204,307	-64%	-$5.15M	1.96%	18
2016 Q2	$7.83M	Sell	316,946 -65,079	-17%	-$1.84M	4%	9
2016 Q1	$11.1M	Buy	382,025 +209,720	+122%	+$5.69M	4.05%	6
2015 Q4	$6.4M	Buy	172,305 +65,296	+61%	+$2.88M	2.83%	12
2015 Q3	$5.21M	Buy	107,009 +77,239	+259%	+$5.4M	3.57%	12
2015 Q2	$2.05M	Buy	+29,770	New	+$1.38M	1.01%	31

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Sio Capital Management's ANTH Position: Q2 2017 in Review

Sio Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 41,714 shares — an estimated $142K sold.

Sio Capital Management first reported a position in ANTH in Q2 2015 and held it in 7 quarters. The position peaked at $11.1M in Q1 2016. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

Sio Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Sio Capital Management sold 41,714 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $142K.
Sio Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
Sio Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $11.1M in Q1 2016.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Sio Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.